Postmastectomy Radiotherapy

Publication Date: December 1, 2016
Last Updated: March 14, 2022

Recommendations

PMRT for patients With T1-2 tumors with one to three positive axillary lymph nodes who undergo ALND

The panel unanimously agreed that the available evidence shows that PMRT reduces the risks of LRF, any recurrence, and breast cancer mortality for patients with T1-2 breast cancer with one to three positive axillary nodes. (EB, H, S)
615

Overview

Title

Postmastectomy Radiotherapy

Authoring Organizations